Single Center Biological Registry Research Articles

THU0104 Risk Factors of Advanced Spinal Disease And/Or Bamboo Disease in Patients with Ankylosing Sponylitis during TNFI Treatments: HÜR-BİO REAL Life Results

BackgroundSpinal ankylosis is most important reason of functional impairment in ankylosing spondylitis (AS). In routine practice, all patients who learned diseases's name ask ankylosing posture and risk factors for ankylosis....

SAT0412 Patients with Psoriatic Arthritis HAD Better TNFI Survival than Ankylosing Spondylitis: HÜR-BİO REAL Life Results

BackgroundTNFi drug survival is one of the valid outcome measure in rheumatological diseases. Patients with psoriatic arthritis (PsA) usually have both joint/back pain diseases and skin disorders. Thus, efficacy of...

SAT0347 Patients with Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis HAD Similar TNFI Drug Survival: HÜR-BİO REAL Life Results

BackgroundTNFi drug survival is one of the valid outcome measure in rheumatological diseases. TNFi drug survival is not evaluated adequetly in non-radiographic axial spondyloarthritis (nr-axSpA).ObjectivesObjective of this study was to...

SAT0370 Retention Rate of TNF Blockers is Greater in CASE of Advanced Spinal Ankylosis in Axial Spondyloarthritis: Data from the HÜR-BİO Registry

BackgroundSpinal ankylosis is one of the important factor responsible of functional impairment in ankylosing spondylitis (AS). In advanced disease, there is still the debate of the potential benefit of use...

SAT0367 Frequency of Radiological Hip Involvement and Total Hip Replacement in A Large Single Center Spondyloarthritis Cohort with Biological Treatments: HÜR-BİO REAL Life Results

BackgroundTotal hip replacement (THR) is a favorable treatment option for severe ankylosing spondylitis (AS). However, THR may be an option for another spondyloarthritis (SpA) such as psoriatic arthritis (PsA) and...